EMIT II Plus Ethyl Alcohol AssayAccurately quantitate ethyl alcohol

It is estimated that nearly 4% of all deaths are related to alcohol worldwide. Most alcohol-related deaths are caused by injuries, cancer, cardiovascular disease, and liver cirrhosis (WHO 2011).

The EMIT® II Plus Ethyl Alcohol Assay has been designed to accurately quantitate ethyl alcohol in urine, serum, and plasma with a recommended cutoff of 40 ng/dL.

Contact Us

Features & Benefits

Ethyl alcohol tests are used for medical and legal purposes that include determining impairment or legal intoxication and diagnosing and treating alcohol dependency and alcohol poisoning.

The EMIT II Plus Ethyl Alcohol Assay provides:

  • No interference from lactate/LDH in post-mortem or trauma patients
  • Applications for multiple sample types, including blood, urine, serum, and plasma
  • Ready-to-use liquid reagents, calibrators, and controls
  • >99% correlation with reference method (GC)

Applications are available for the Viva-Jr®, Viva-E®, Viva-ProE®, V-Twin® drug testing systems and AU® Series analyzers.



Technical Specifications

 Assay Principle

  Homogeneous Enzyme Multiplied Immonoassay (EMIT)


  40 ng/dL (recommended)


  Urine, serum, or plasma

 Reagent Stability

  Unopened: until expiration date. Onboard instrument: up to 4 weeks

 Calibration Frequency

  As indicated by control results